Centre for Biotechnology and Biomedicine (BBZ), University of Leipzig, Division of Molecular Biological-Biochemical Processing Technology, D-04103 Leipzig, Germany.
CECS, I-STEM, AFM, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, Genopole Campus 1, 5 rue Henri Desbruères, 91030 Evry Cedex, France.
Analyst. 2017 May 30;142(11):1929-1937. doi: 10.1039/c6an02713j.
Due to the lack of appropriate cell models as well as automated electrophysiology monitoring technologies, the standardized identification of neurotoxic or protective effects in vitro remains a major problem in today's pharmaceutical ingredient development. Over the past few years, in vivo-like human pluripotent stem cell-derived neuronal networks have turned out to be a promising physiological cell source, if the establishment of robust and time-saving functional maturation strategies based on stable and expandable neural progenitor populations can be achieved. Here, we describe a multi-microelectrode array (MMEA)-based bioelectronics platform that was optimized for long-term electrophysiological activity monitoring of neuronal networks via field potential measurements. Differentiation of small molecule-based neuronal progenitors on MMEAs led to functional neurons within 15 days. More strikingly, these functional neuronal cultures could remain electrophysiologically stable on the MMEAs for more than four weeks. The observed electrophysiological properties correlated with the expression of typical neuron subtype markers and were further validated by specific neurotransmitter applications. With our established monitoring platform, we could show for the first time the long-term stability of the neural stem cell-like progenitor population to differentiate to electrophysiologically active dopaminergic neuronal networks for more than 80 passages. In conclusion, we provide a comprehensive long-term stable field potential monitoring platform based on stem cell-derived human neuronal networks that can be automated and up-scaled for standardized high-content screening applications e.g. in the field of neurotoxic and neuroprotective therapeutics identification.
由于缺乏合适的细胞模型以及自动化电生理学监测技术,标准化鉴定体外的神经毒性或保护作用仍然是当今药物成分开发中的一个主要问题。在过去的几年中,类似于体内的人类多能干细胞衍生的神经元网络已被证明是一种有前途的生理细胞来源,如果能够建立基于稳定且可扩增的神经祖细胞群体的稳健且省时的功能成熟策略。在这里,我们描述了一种基于多微电极阵列(MMEA)的生物电子平台,该平台经过优化,可通过场电位测量对神经元网络进行长期电生理活性监测。在 MMEA 上对小分子基神经元祖细胞进行分化可在 15 天内产生功能性神经元。更引人注目的是,这些功能性神经元培养物在 MMEA 上可保持电生理稳定超过四周。观察到的电生理特性与典型神经元亚型标志物的表达相关,并通过特定的神经递质应用进一步验证。使用我们建立的监测平台,我们首次展示了神经干细胞样祖细胞群体向具有长期电生理稳定性的多巴胺能神经元网络分化的能力,可超过 80 代。总之,我们提供了一种基于干细胞衍生的人类神经元网络的全面的长期稳定的场电位监测平台,该平台可自动化并扩展,用于标准化的高通量筛选应用,例如在神经毒性和神经保护治疗剂鉴定领域。